Generation of Perinatal-like Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells

Zhen Ma (Inventor), Tackla Winston (Inventor)

Research output: Patent

Abstract

Non-naturally occurring perinatal mesenchymal stem cells differentiated from human induced pluripotent stem cells. The differentiation medium includes an amount of SB431542, an
amount of BMP-4, and an amount of PD173074 and is repeated over the course of six days
period until perinatal mesenchymal stem-like cells are formed. The resulting non-naturally
occurring perinatal mesenchymal stem cells exhibit the relevant characteristics of naturally
occurring perinatal mesenchymal stem cells, such as the positive expression of the mesenchymal
stem cell markers CD73, CD90, and CD105. The non-naturally occurring perinatal mesenchymal stem cells may be used to produce paracrine factors and similar compounds for therapeutic purposes.
Original languageEnglish (US)
Priority date6/24/20
Filing date6/22/21
StatePublished - Dec 30 2021

Fingerprint

Dive into the research topics of 'Generation of Perinatal-like Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells'. Together they form a unique fingerprint.

Cite this